Type 2 Diabetes Remission With Intensive Treatment

Theory proposed that type 2 diabetes can be reversed in the short term with medical approaches over bariatric surgeries.
Type 2 diabetes can be acquired over time when a person makes poor lifestyle choices with their diet and lives a sedentary lifestyle. Eventually, it progresses to a chronic state with additional complications, but it can be reversed with lifestyle approaches and a series of oral and injectable medications. According to the Society’s Endocrine Facts and Figures, one in 10 American adults has type 2 diabetes and either cannot produce enough insulin or their pancreas is not making insulin efficiently. Thus, resulting in an increase in blood sugar and keeping the cells from receiving energy. Ongoing studies have stressed treating type 2 diabetes by reversing the disease rather than controlling its progression by achieving normoglycemia.
Recent studies show that intensive medical treatment for two to four months, using oral medications, insulin and lifestyle therapies may help reverse type 2 diabetes. In an open-labeled, parallel, randomized pilot trial, a short-term intensive metabolic approach was conducted to target the fasting and postprandial normoglycemia and weight loss using a combination of pharmacological and lifestyle approaches to induce sustained diabetes remission. The objective of the study was to assess the feasibility, safety, and potential to induce remission of a short-term intensive metabolic strategy. All analyses were performed using the intention-to-treat principle. A chi-square test and two sample t-test was used to compare dichotomou Continue reading

Rate this article

Total 1 ratings

Diabetes increase putting NHS future 'at stake'

INDYPULSE
Diabetes increase putting NHS future 'at stake'
Tackling diabetes is “fundamental” to the future of NHS as the number of adults with the condition nears four million, Public Health England has warned.
Around 3.8 million adults in England now have diabetes, with at least 940,000 of those undiagnosed, new figures have revealed.
About 90 per cent of the cases are Type 2 diabetes, which is linked to being overweight and obese and therefore largely preventable, PHE, who released the data, said.
The other 10 per cent are Type 1, which usually develops in childhood and is often inherited.
Diabetes can lead to serious health complications including limb amputation, kidney disease, stroke and heart attacks. Treating the disease and the complications arising from it costs the NHS around £10 billion annually.
John Newton, chief knowledge officer at PHE, said: "The number of people with diabetes has been steadily increasing and tackling it is fundamental to the sustainable future of the NHS.
"Diabetes can be an extremely serious disease for those that have it and treating it and its complications costs the NHS almost £10bn a year.
"Developing Type 2 diabetes is not an inevitable part of ageing. We have an opportunity through public health to reverse this trend and safeguard the health of the nation and the future of the NHS."
The new Diabetes Prevalence Model was launched ahead of PHE's conference at Warwick University. It shows that 9 per cent of people aged 45 to 54 have diabetes, but this rises to 23.8 per cent of those aged over 75.
Earlier this month, senior health Continue reading

Get off your backside! It's madness for the NHS to spend millions fighting type 2 diabetes when the simple cure is exercise, says DR MICHAEL MOSLEY, who reversed HIS own diabetes

When my father was in his 60s, he was told that he had type 2 diabetes. We didn’t know it at the time, but it would contribute to his premature death.
Diabetes can cause multiple complications and, at the relatively young age of 74, my father died, suffering from prostate cancer, heart disease and what I now suspect was early dementia.
So when I went for a routine blood test five years ago, aged 55, and discovered that my blood sugar was in the diabetic range, I was shocked and worried.
The accepted wisdom is that type 2 is incurable. My doctor told me I should start on medication.
I did not accept it. Instead, I came across research pointing to the importance of weight loss in controlling and possibly reversing diabetes. I lost 19 lb in 12 weeks, and my blood sugar and cholesterol levels returned to normal — where they have stayed since.
With the help of science and some self-discipline, I sorted myself out. And there is nothing unusual about that: knowing what to do and then doing it is the way to better health.
Last week, Professor Sir Muir Gray, one of Britain’s most eminent doctors, said that he didn’t consider type 2 diabetes to be a ‘real disease’. As reported in the Mail, he told a shocked audience at Oxford Literary Festival that it was a reversible illness caused by the ‘modern environment’ and our sedentary lifestyles.
He said it ought to be known as ‘walking deficiency syndrome’.
It is a controversial view and while it is certainly alarming that, according to new NHS figures, one in four people fail to manage to take even 30 minutes exercise Continue reading

NHS screening plan for type 2 diabetes 'inaccurate'

The NHS programme for screening those at high risk of type 2 diabetes is unlikely to have much impact, an Oxford University study in the BMJ suggests.
It concluded that inaccurate blood tests would give too many people an incorrect diagnosis, while lifestyle changes had a low success rate.
But the director of the NHS programme said its approach was based on "robust evidence".
The programme started last year and will cover all of England by 2020.
Type 2 diabetes leads to 22,000 early deaths every year in England and costs the NHS £8bn.
In the UK, about 3.2 million people have type 2 diabetes and this is predicted to rise to 5 million by 2025.
The UK's National Diabetes Prevention Programme, which aims to identify thousands of people at high risk of developing the condition each year, follows a "screen and treat" approach.
This involves a screening test for pre-diabetes, then tailored treatment or advice on diet and lifestyle to prevent the disease developing.
'Falsely reassured'
But after analysing the results of 49 studies of screening tests and 50 intervention trials, University of Oxford researchers said the policy would benefit some, but not all those at high risk.
They also said a population-wide approach to diabetes prevention would be a useful addition.
In the BMJ study, they found that two blood tests - HbA1c and fasting plasma glucose - were inaccurate at detecting pre-diabetes, although they are the only ones available to doctors and patients.
They also found that lifestyle interventions lasting three to six years showed a 37% reduction in relative risk of type 2 Continue reading

BREAKING: Flash glucose sensing available on NHS for type 1 diabetes from November

A device which checks blood glucose levels by scanning a sensor worn on their arm will be available on the NHS for people with type 1 diabetes, it was announced today.
The ‘Freestyle Libre’, from the healthcare firm Abbott, is currently the only flash glucose sensing device in existence.
The device will, subject to local health authority approval, be available on the NHS across the United Kingdom from 1st November 2017.
Flash glucose sensing is a recent development in glucose monitoring. It uses a sensor the size of a £2 coin and sits on the back of the arm with a probe just under the skin.
By ‘flashing’ the sensor with a scanning device, the user receives a blood glucose level reading, a graph of blood glucose levels for the previous eight hours and a direction arrow showing if their levels are going up or down.
Evidence shows that flash glucose monitoring can help people with type 1 diabetes manage their condition and keep in good health.
Of today’s news, Karen Addington, JDRF’s UK Chief Executive said:
“Today’s announcement is good news for people living with type 1 diabetes. But it is vital that the technology actually reaches those who want it and would benefit. There is a postcode lottery of NHS provision of type 1 diabetes technology. This is despite such devices making daily life with type 1 diabetes much easier.
“Each and every person with type 1 diabetes who wants this technology, and would benefit, should receive it. JDRF will continue to campaign in Westminster and devolved governments on this issue.”
JDRF has produced a guide to type 1 diab Continue reading